Rocket Pharmaceuticals (RCKT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
20 May, 2026Opening remarks and agenda
Chairman welcomed attendees and introduced board members and officers present in person and virtually.
Meeting called to order, with formal business to follow as outlined in the notice and proxy statement.
Corporate governance
Record date for stockholders set as March 24, 2026, with proper notice and documentation confirmed.
Tracy Oates appointed as Independent Inspector of Election to oversee voting and certify results.
Quorum established with proxies representing 74.2% of outstanding shares.
Shareholder proposals
Four proposals presented: election of seven directors, ratification of accounting firm, advisory vote on executive compensation, and approval of stock option exchange program.
No discussion or questions raised for any of the proposals.
Latest events from Rocket Pharmaceuticals
- FDA clears pivotal Danon gene therapy trial; robust pipeline and cash runway support growth.RCKT
Morgan Stanley 24th Annual Global Healthcare Conference - Danon pivotal trial resumes at recalibrated dose with FDA alignment and strong safety profile.RCKT
Study update - Gene therapy pipeline advances with pivotal Danon trial, KRESLADI launch, and robust patient outreach.RCKT
12th Annual Cantor Fitzgerald Global Healthcare Conference - Q2 2026 net income hit $123.2M on PRV sale; FDA approval and strong cash support pipeline.RCKT
Q2 2026 - Early phase I data show RP-A601 improves cardiac function and arrhythmia burden at a safe dose.RCKT
Status Update - Cardiac gene therapy pipeline advances with pivotal trials and strong financial runway.RCKT
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Cardiac gene therapy pipeline advances with pivotal trials and major updates expected this year.RCKT
Jefferies Global Healthcare Conference 2026 - Accelerated approval, $180M PRV sale, and reduced expenses extend cash runway into 2028.RCKT
Q1 2026 - RP-A501 gene therapy achieved lasting cardiac and symptomatic improvements in Danon disease.RCKT
Study Update